1
2
3
Vervloet, Marc G., de Jong, Hilda Ji, Pander, Jan, Overbeek, Jetty A.
Veröffentlicht in: Vervloet , M G , de Jong , H J , Pander , J & Overbeek , J A 2023 , ' Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications ' , BMC Nephrology , vol. 24 , no. 1 , 337 . https://doi.org/10.1186/s12882-023-03384-y;
2023
Veröffentlicht in: Vervloet , M G , de Jong , H J , Pander , J & Overbeek , J A 2023 , ' Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications ' , BMC Nephrology , vol. 24 , no. 1 , 337 . https://doi.org/10.1186/s12882-023-03384-y;
2023
4
Cherney, David Z I, Dekkers, Claire C J, Barbour, Sean J, Cattran, Daniel, Abdul Gafor, Abdul Halim, Greasley, Peter J, Laverman, Gozewijn D, Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N, Vervloet, Marc G, Wong, Muh Geot, Gansevoort, Ron T, Heerspink, Hiddo J L
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020
Veröffentlicht in: DIAMOND investigators , Cherney , D Z I , Dekkers , C C J , Barbour , S J , Cattran , D , Abdul Gafor , A H , Greasley , P J , Laverman , G D , Lim , S K , Di Tanna , G L , Reich , H N , Vervloet , M G , Wong , M G , Gansevoort , R T & Heerspink , H J L 2020 , ' Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND) : a randomised, double-blind, crossover trial ' , Lancet Diabetes & Endocrinology , vol. 8 , no. 7 , pp. 582-593 . https://doi.org/10.1016/S2213-8587(20)30162-5;
2020